Nearly Half of Type 2 Diabetics Have Undiagnosed CKD
Undiagnosed chronic kidney disease is present in 49% of patients with type 2 diabetes mellitus in the United States, a study found.
Diabetic Nephropathy
Atrasentan Tied to Lower Risk for Kidney Events in T2DM With CKD
Reduced risk seen for primary composite renal end point event; more frequent fluid retention, anemia reported
Nondihydropyridine CCBs May Be an Effective Treatment Option for Proteinuria in Certain Patients
Nondihydropyridine calcium channel blockers (non-DHP CCBs) appear to reduce proteinuria in patients with diabetic kidney disease
Canagliflozin Lowers ESRD Risk in Diabetic Kidney Disease
In a study of patients with type 2 diabetes and chronic kidney disease, canagliflozin, an SGLT2 inhibitor, decreased the risk of end-stage renal disease by 32% compared with placebo.
Higher Glucose Levels at Dialysis Transition Increase Mortality Risk
New findings suggest that diabetic patients with advanced chronic kidney disease may need different glucose control strategies depending on whether or not they are transitioning to dialysis.
SGLT2 Inhibitors May Reduce CV, Renal Risks in Type 2 Diabetes
SGLT2i reduced the risks for progression of renal disease by 45% and heart failure hospitalization by 31% in patients with type 2 diabetes.
Bardoxolone Methyl Leads to Weight Loss in T2D With Concurrent Chronic Kidney Disease
Treatment with bardoxolone methyl resulted in significant weight loss and showed no evidence of muscle wasting in patients with type 2 diabetes and stage IV chronic kidney disease.
Aggressive Control of BP, Lipids in T2DM May Up Kidney Risk
Strict BP control, fenofibrate use may increase long-term risk for adverse kidney events in T2DM patients
ADA, EASD Issue New Recommendations for T2DM
Additional focus on lifestyle management, self-management education and support emphasized
Metformin Can Be Used Safely at Lower Levels of Renal Function
New study shows metformin is not associated with an increased risk of acidosis in patients with type 2 diabetes and an eGFR of 30 to 60 mL/min/1.73 m2.
Next post in Diabetic Nephropathy
